Free Republic

Pfizer BrandsPrescription Aricept® (donepezil hydrochloride tablets) Bextra® (valdecoxib) Celebrex® (celecoxib) Lipitor® (atorvastatin calcium) tablets Relpax® (eletriptan HBr) Viagra® (sildenafil citrate) tablets Viracept® (nelfinavir mesylate) Xalatan® (latanoprost ophthalmic solution) Zoloft® (sertraline HCl) Zyrtec® (cetirizine HCl) Over-the-Counter Brands Benadryl Listerine Mouthwash Listerine PocketPaks Neosporin Purell Rogaine Rolaids Sudafed Visine Zantac Lets face it, if Pfizer had not wanted the land, then the SC never would have made the ruling. Hit Pfizer where it hurts, in the pocketbook.

The drugs now available to treat the memory and thinking problems of Alzheimer's disease have not lived up to the public's high expectations for them and offer such modest benefits on average that many doctors are unsure about whether to prescribe them. Although the drugs have their advocates, grateful for any sign of improvement, others express disappointment in light of earlier hopes that the drugs approved in the last decade would stop the disease or markedly slow it. At a meeting in late March at Johns Hopkins University, doctors and other health professionals heard Alzheimer's researchers debate the usefulness of...